Symbol1J5
NameHYPHENS PHARMA INTERNATIONAL LIMITED
SectorUNDEFINED
RegionAsia
Industry-
Address16 Tai Seng Street #04-01 Singapore 534138
Telephone-
Fax-
Emaillimsw@hyphens.com.sg
Websitehttps://www.hyphensgroup.com
IncorporationSINGAPORE
Incorporated On12 Dec 2017
Employees-
Fiscal Year-
Public Since-
ExchangesSGX
AuditorRSM SG ASSURANCE LLP
Audit StatusNOT PROVIDED
Reporting Status
CIK
Description


Hyphens Pharma International Limited and its subsidiaries (the "Group") is one of Singapores leading specialty pharmaceutical and consumer healthcare groups leveraging on its diverse footprint in ASEAN countries. The Group has a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia and the Philippines, supplemented by a marketing and distribution network covering five additional jurisdictions, namely, Hong Kong, Myanmar, Brunei, Cambodia and Oman. Singapore is the Groups regional headquarters, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based.
The Groups core business comprises the following segments: specialty pharma principals, proprietary brands, and medical hypermart and digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies.

Additional info from SGX:

Hyphens Pharma International Limited and its subsidiaries (the "Group") is one of Singapores leading specialty pharmaceutical and consumer healthcare groups leveraging on its diverse footprint in ASEAN countries. The Group has a direct presence in five ASEAN countries, namely, Singapore, Vietnam, Malaysia, Indonesia and the Philippines, supplemented by a marketing and distribution network covering five additional jurisdictions, namely, Hong Kong, Myanmar, Brunei, Cambodia and Oman. Singapore is the Groups regional headquarters, where its strategic planning, finance, regulatory affairs, research and development, legal, business development and logistics operations are based.
The Groups core business comprises the following segments: specialty pharma principals, proprietary brands, and medical hypermart and digital. Besides marketing and selling a range of specialty pharmaceutical products in selected ASEAN countries through exclusive distributorship or licensing and supply agreements with brand principals mainly from Europe and the United States, the Group also develops, markets and sells its own proprietary range of dermatological products and health supplement products. In addition, the Group operates a medical hypermart for healthcare professionals, healthcare institutions and retail pharmacies, to supply pharmaceutical products and medical supplies.

2026-04-17 09:38

Annual Reports and Related Documents:

Read more
2026-04-10 05:05

Hyphens Notification - Evolve Capitals Equity Research - No clear catalysts, FY26 recovery a low-bar normalisation

Read more
2026-04-10 03:06

Hyphens Notification - Mandatory Cash Dividend / Distribution (FY2025)

Read more
2026-04-10 02:50

Hyphens Notification - Annual Report FY2025

Read more
2026-04-10 02:35

Hyphens Notification - Notice of Annual General Meeting (FY2025)

Read more
2026-04-09 22:58

Mandatory Cash Dividend/ Distribution:

Read more
2026-04-09 22:57

Annual Report FY2025

Read more
2026-04-09 22:57

Mandatory Cash Dividend / Distribution (FY2025)

Read more
2026-04-09 22:57

Annual Reports and Related Documents:

Read more
2026-04-09 22:56

Annual General Meeting :

Read more